The logical underpinnings and benefits of pooled pharmaceutical procurement: A pragmatic role for our public institutions?

Social Science and Medicine

Volumn 75, Issue 9, 2012, Pages 1572-1580

  Huff Rousselle, Maggie ^a,b,c  

^a TULANE UNIVERSITY   (United States)

^b BOSTON UNIVERSITY   (United States)

^c Massachusetts School of Pharmacy and Health Services   (United States)

Author keywords

Buyers' cartel; Contraceptives; Economies of scale; Essential drugs; Monopsony; Multi country; Pharmaceuticals; Pooled procurement; Vaccines

Indexed keywords

DRUG; ECONOMY OF SCALE; INSTITUTIONAL FRAMEWORK; LITERATURE REVIEW; MARKET CONDITIONS; MULTINATIONAL ENTERPRISE; PHARMACEUTICAL INDUSTRY; PURCHASING POWER PARITY;

COST BENEFIT ANALYSIS; COST CONTROL; COST EFFECTIVENESS ANALYSIS; COST MINIMIZATION ANALYSIS; COST UTILITY ANALYSIS; DRUG INDUSTRY; FUNDING; HEALTH CARE ACCESS; HEALTH CARE AVAILABILITY; HEALTH CARE COST; HEALTH CARE NEED; HUMAN; MARKETING; PUBLIC HEALTH SERVICE; PURCHASING; QUALITY CONTROL; REVIEW; SOCIAL NETWORK; STANDARDIZATION;

COST CONTROL; COST-BENEFIT ANALYSIS; DRUG INDUSTRY; GROUP PURCHASING; HUMANS; INTERNATIONALITY; PHARMACEUTICAL PREPARATIONS; PUBLIC SECTOR;

EID: 84865614207     PISSN: 02779536     EISSN: 18735347     Source Type: Journal    
DOI: 10.1016/j.socscimed.2012.05.044     Document Type: Review

References (33)

1. Abdallah H., Aronovich D., Diarra A., Dowling P., Hare L., Kagone M., et al. The West Africa reproductive health commodity security study: Summary of findings from phase one 2004, John Snow, Inc. USAID-funded DELIVER Project, Arlington, VA.
2. Abramson J. Overdosed America: The broken promise of American medicine 2004, Harper Collins, New York.
3. Angell M. The truth about the drug companies: How they deceive us and what to do about it 2004, Random House, New York.
4. Avorn J. Powerful medicines: The benefits, risks, and costs of prescription drug 2004, Alfred A. Knopf, New York.
5. Beith A., Olson N., Abramson W. Regulatory harmonization in central America: How harmonization can impact regional contraceptive procurement 2007, John Snow, Inc. USAID-funded DELIVER Project, Arlington, VA.
6. Bogdanich W. Free trade zones can ease passage of counterfeit drugs. New York Times December 17, 2007.
7. Center for Pharmaceutical Management Regional pooled procurement of drugs: Evaluation of programs 2002, Submitted to the Rockefeller Foundation, Management Sciences for Health, Arlington, VA.
8. Center for Pharmaceutical Management An analysis of the OECS/PPS regional program using key performance indicators, 1992-2002 2003, Submitted to the Rockefeller Foundation, Management Sciences for Health, Arlington, VA.
9. Center for Pharmaceutical Management Business strategy for regional pooled procurement of HIV/AIDS-related pharmaceuticals and commodities in the ACAME region 2003, Submitted to the Rockefeller Foundation, Management Sciences for Health, Arlington, VA.
10. Center for Pharmaceutical Management Business strategy for regional pooled procurement of HIV/AIDS-related pharmaceuticals and commodities in east, central, and Southern Africa 2003, Submitted to the Rockefeller Foundation, Management Sciences for Health, Arlington, VA.
11. Chokshi D.A., Kesselheim A.S. Rethinking global access to vaccines. British Medical Journal 2008, 336:750-753.
12. DeRoeck D. Group procurement of vaccines for central/eastern Europe and newly independent states: Feasibility, issues, and options 2003, Feasibility Study, funded by PATH and the World Health Organization.
13. DeRoeck D., Bawazir S.A., Carrasco P., Kaddar M., Brooks A., Fitzsimmons J., et al. Regional group purchasing of vaccines: review of the Pan American Health Organization EPI revolving fund and the Gulf Cooperation Council group purchasing program. The International Journal of Health Planning and Management 2006, 21:23-43.
14. Global Fund Web page on Affordable Medicines Facility AMFm - malaria at Global Fund 2009, at, Accessed 13.09.09. http://www.theglobalfund.org/en/amfm/.
15. Hawthorne F. Inside the FDA: The business and politics behind the drugs we take and the food we eat 2005, John Wiley & Sons, Hoboken, New Jersey.
16. Hsiao W. Abnormal economics in the health sector. Health Policy 1995, 32:125-139.
17. Huff-Rousselle M. Lessons from the Eastern Caribbean to the Pacific Islands: To do or not to do pooled procurement, and, if so, how? 2005, Social Sectors Development Strategies (SSDS), for the World Bank, Boston, MA.
18. Huff-Rousselle M., Burnett F. Cost containment through pharmaceutical procurement: a Caribbean case study. The International Journal of Health Planning and Management 1996, 11:135-157.
19. Huff-Rousselle M., Raja S. Ghana: Estimating the cost of logistics in the ministry of health supply system 2002, Family Planning Logistics Management (FPLM)/John Snow, Inc., for the U.S. Agency for International Development, Arlington, Va.
20. Huff-Rousselle M., Scheffer A., Kumire C. Evaluation of Kenya Medical Supplies Agency (KEMSA) 2006, DFID/USAID, Nairobi.
21. Kumaresan J., Smith I., Arnold V., Evans P. The global TB drug facility: innovative global procurement. International Journal of Tuberculosis and Lung Disease 2004, 8(1):130-138.
22. NYT Drug industry consolidation: a series of mergers has winnowed the drug industry to a few major players. New York Times March 13, 2009.
23. Onyango C., Aboagye-Nyame F. Readiness for regional pooled procurement of HIV/AIDS-related drugs and commodities in sub-Saharan Africa: An assessment of 11 member countries of the commonwealth regional health community secretariat, 2002 2003, Submitted to the U.S. Agency for International Development by the Rational Pharmaceutical Management Plus Program, Management Sciences for Health, Arlington, VA.
24. PBS Home Video., PBS Home Video., PBS DVD (Firm), & WGBH (Television station: Boston, Mass.) The other drug war 2003, PBS Home Video, Alexandia, Va.
25. RHSC Reproductive health financial mechanism analysis, business plan 2006, Reproductive Health Supplies Coalition (RHSC): Systems Strengthening Working Group. Analytical support provided by McKinsey & Company, dated July, 2006. Permission granted to cite document at, Accessed 02.01.08. http://www.rhsupplies.org/pdf/McKinseyRHFinancialMechanismAnalysisBusinessPlanJuly%25202006.pdf.
26. Sarley D., Dayaratna V., Abramson W., Gribble J., Quesada N., Olson N., et al. Options for contraceptive procurement: Lessons learned from Latin America and the Caribbean 2006, DELIVER, and Washington, DC: USAID | Health Policy Initiative, for the U.S. Agency for International Development, Arlington, Va.
27. Vladeck B., Rice T. Market failure and the failure of discourse: facing up to the power of sellers. Health Affairs 2009, 28(No. 5).
28. Waning B., Kaplan W., King A.C., Lawrence D.A., Leufkens H.G., Fox M.P. Global strategies to reduce the price of antiretroviral medicines: evidence from transactional databases. Bulletine of the World Health Organization 2009, 87:520-528.
29. WHO Association africaine des centrales d'achats de médicaments essentiels (ACAME) Achats groupés de médicaments essentiels 1999, WHO, Regional Office for Africa, Harare, Zimbabwe.
30. WHO Report of a study tour to the secretariats of bulk purchasing systems in the Maghreb and Gulf States 1999, African Association of Central Medical Stores for Generic Essential Drugs, in collaboration with the WHO Regional Office for Africa, Geneva.
31. WHO. (2006). Task Force on Immunization (TFI) in Africa 14th annual meeting and Africa Regional Inter-Agency Coordination Committee (ARICC) 13th annual meeting. Meeting Report, Maputo, Mozambique, 27-29 November, 2006.
32. WHO. (2007). Multi-country regional pooled procurement of medicines: Identifying key principles for enabling regional pooled procurement and a framework for inter-regional collaboration in the African, Caribbean and Pacific Island Countries. Meeting Report, Geneva, Switzerland, 15-16 January, 2007.
33. WHO. (Undated). Note technique sur l'expérience d'indépendance vaccinale dans les pays membres de ARIVA. An analysis done by a WHO/AFRO economist base on 10 documents about the ARIVA experience.